维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

14篇 您的检索式：作者名="Conkling P"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Randomized phase II trial of single-agent amrubicin or topotecan as second-line treatment in patients with small-cell lung cancer sensitive to first-line platinum- based chemotherapy显示文摘	Jotte R Conkling P Reynolds C	2011	J Clin Oncol2011，29，3：	1
	2	Tumor necrosis factor induces tissue factor-like activity in human leukemia cell line 13937 and peripheral blood monocytes显示文摘	Conkling P R Greenberg C S Weinherg J B	1998	Blood1998，72，：	1
	3	Randomized phase Ⅱ trial of single-agent amrubicin or topotecan as second-line treatment in patients with small-cell lung cancer sensitive to first-line platinum- based chemotherapy 显示文摘	Jotte R Conkling P Reynolds C	2011	J Clin Onco12011，29，3：	1
	4	Pharmacokinetic (PK) analysis of a phase I study of continuous oral treatment with the angiokinase inhibitor B1BF 1120, in combination with carboplatin and paclitaxel in patients with advanced non-small cell lung cancer (NSCLC) 显示文摘	Camidge R Conkling P Stephenson J J	2008	J Clin Oncol2008，26，15：	1
	5	Results of a randomized phase II trial of amrubicin(AMR)versus topotecan(Topo)in patients with extensive disease small cell lung cancer(ED-SCLC)sensitive to first-line platinum based chemotherapy显示文摘	Jotte R Conkling P Reynolds C	2009	J Clin Oncol2009，，：	1
	6	Randomized phase II trial of single-agent amrubicin or topotecan as second-line treatment in patients with small-cell lung cancer sensitive to first-line platinum-based chemotherapy 显示文摘	Jotte R Conkling P Reynolds C	2011	J Clin Oncol2011，29，3：	1
	7	A phase I, open-label dose-escalation study of continuous treatment with BIBF 1120 in combination with paclitaxel and carboplatin as first-line treatment in patients with advanced non-small-cell lung cancer 显示文摘	Doebele RC Conkling P Traynor AM	2012	Annals of Oncology2012，23，8：	1
	8	Randomized phase I1 trial of single-agent Amrubicin or Topotecan as second-line treatment in patients with small-cell lung cancer sensitive to first-line platinum-based chemotherapy显示文摘	Jotte R Conkling P Reynolds C	2011	J Clin Oncol2011，29，3：	1
	9	Randomized phase II trial of single-agent amrubicin or topotecan as second-line treatment in patients with small-cell lung cancer sensitive to first- line platinum-based chemotherapy显示文摘	Jotte R Conkling P Reynolds C	2011	J Clin Oncol2011，29，3：	1
	10	Randomized phase Ⅱ trial of single-agent amrubicin or topotecan as second-line treatment in patients with small-cell lung cancer sensitive to first-line platinumbased chemotherapy显示文摘	Jotte R Conkling P Reynolds C		0，，03：	1
	11	Randomized phase II trial of single-agent amrubicin or topotecan as second-line treatment in patients with small-cell lung cancer sensitive to first-line platinum-based chemotherapy 显示文摘	Jotte R Conkling P Reynolds C	2011	J Clin Oncol2011，29，3：	1
	12	A phase I, open-label dose-escalation study of continuous treatment with BIBF 1120 in combination with paclitaxel and carboplatin as first-line treatment in patients with advanced non-small-cell lung cancer显示文摘	Doebele RC Conkling P Traynor AM	2012	Ann Oncol2012，23，8：	1
	13	Randomized Phase Ⅱ trial of single-agent amrubicin or topotecan as second-line treatment in patients with small-cell lung cancer sensitive to first-line platinum-based chemotherapy显示文摘	Jotte R Conkling P Reynolds C	2011	J Clin Oncol2011，29，3：	1
	14	Results of a randomized phase II trial of amrubicin (AMR) versus topotecan (Topo) in patients with extensive-disease small cell lung cancer (ED-SCLC) sensitive to first-line platinum-based chemotherapy显示文摘	Jotte R Conkling P Reynolds C	2009	J Clin On- col2009，27，：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费